Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.180
+0.030 (2.61%)
At close: May 18, 2026, 4:00 PM EDT
1.190
+0.010 (0.85%)
After-hours: May 18, 2026, 4:49 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $73.07 million as of May 18, 2026. Its market cap has decreased by -26.53% in one year.
Market Cap
73.07M
Enterprise Value
-70.90M
1-Year Change
-26.53%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $73.07M, a decrease of -90.09%. That is a compound annual growth rate of -32.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 71.21M | -5.02% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MAIA Biotechnology | 76.45M |
| Acrivon Therapeutics | 75.76M |
| Rallybio | 75.64M |
| XBiotech | 75.00M |
| Cue Biopharma | 74.91M |
| PDS Biotechnology | 74.79M |
| Gain Therapeutics | 74.64M |
| Seres Therapeutics | 73.99M |